auph-20260603

Alberta, Canada

001-36421

98-1231763

(State or Other Jurisdiction of Incorporation)

(Commission File No.)

(IRS Employer Identification No.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on which Registered

Common Shares, without par value

AUPH

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

(a)Aurinia Pharmaceuticals Inc. (the "Corporation") held its annual general meeting of shareholders virtually on June 3, 2026 (the "2026 Meeting").

(b)The following proposals were voted upon at the 2026 Meeting and the final voting results with respect to each such proposal are set forth below:

Proposal 1: Based upon the following votes, the shareholders elected Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova to serve as members of the Corporation's board of directors until the annual general meeting of shareholders to be held in 2027.


	Number of Shares			Percentage of Votes Cast
Nominee	For	Withheld	Broker Non-Votes	For	Against	Withheld/Abstain
Kevin Tang	68,889,411	2,434,090	16,049,984	96.59%	0.00%	3.41%
Jeffrey Bailey	67,990,723	3,332,778	16,049,984	95.33%	0.00%	4.67%
Kathy Goetz	68,840,807	2,482,694	16,049,984	96.52%	0.00%	3.48%
Craig Johnson	61,694,786	9,628,715	16,049,984	86.50%	0.00%	13.50%
Tina S. Nova	61,972,942	9,350,560	16,049,983	86.89%	0.00%	13.11%

Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2027 or until a successor is appointed.


Number of Shares			Percentage of Votes Cast
For	Withhold	Broker Non-Votes	For	Against	Withheld/Abstain
77,785,132	9,488,350	3	89.14%	0.00%	10.86%

Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a “say on pay” resolution regarding the Corporation's executive compensation.


Number of Shares				Percentage of Votes Cast
For	Against	Abstain	Broker Non-Votes	For	Against	Withheld/Abstain
66,398,971	4,315,143	609,384	16,049,987	93.10%	6.05%	0.85%


Exhibit No.						Description

104						Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



						AURINIA PHARMACEUTICALS INC.

			By:			/s/ Stephen P. Robertson
			Name:			Stephen P. Robertson
			Title:			Chief Legal Officer, Corporate Secretary and Chief Compliance Officer


Item 5.07			Submission of Matters to a Vote of Security Holders.


Item 9.01			Financial Statements and Exhibits